Cancer is a sneaky disease. Find one method of treating it successfully, and it finds another way to survive. Take, for example, pediatric diffuse midline gliomas, brain tumors that are among the most ...

Crizotinib in Combination With Chemotherapy for Pediatric Patients With ALK+ Anaplastic Large-Cell Lymphoma: The Results of Children's Oncology Group Trial ANHL12P1 In a 20-year retrospective cohort ...

Please provide your email address to receive an email when new articles are posted on . Three of four patients who received an investigational chimeric antigen receptor T-cell therapy for diffuse ...

ARLINGTON, Va., June 26, 2025 — A new clinical guideline from the American Society for Radiation Oncology (ASTRO) focuses on the use of radiation therapy to treat adult patients with World Health ...

Please provide your email address to receive an email when new articles are posted on . Researchers recently presented early data on the efficacy of chimeric antigen receptor T-cell therapy for ...

“Receiving the Rare Pediatric Disease Designation for NEO100 is a crucial step forward in our mission to develop effective treatments for children facing diffuse high-grade gliomas,” said Dr. Thomas ...

1 Emma Children’s Hospital, Amsterdam UMC – location VUmc, Department of Pediatric Oncology, Cancer Center Amsterdam, de Boelelaan 1117, Amsterdam, The Netherlands 2 Princess Máxima Center for ...

This trial looked at temozolomide during and after radiotherapy for children and young people with brain tumours called diffuse pontine gliomas. This trial was supported by Cancer Research UK. This ...